TP53 and glioblastoma: Amounting of recent studies have shown that not only does TP53 serve a central role in the regulatory network of tumorigenesis, but also its status is closely associated with the disease progression and survival of patients with GBM during radio/chemo therapy49,50; this gene is also considered as a targeted therapy for cancer treatment6.